Transcarent to Acquire Accolade

Jan 8, 2025 · SAN FRANCISCO and SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and primary care, announced that they have …

$7.03
OFF

Accolade To Be Acquired By Transcarent For $7.03 Per Share

2 weeks from now

Jan 8, 2025 · Transcarent and Accolade (ACCD) announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share in …

businessinsider.com

$621
OFF

Accolade To Be Acquired By Telehealth Startup In $621 Million Deal ...

2 weeks from now

6 days ago · The companies expect the deal to close in the second quarter. Seattle-based health care company Accolade Inc. (Nasaq: ACCD) is being acquired by telehealth startup …

bizjournals.com

$621
OFF

Transcarent To Acquire Accolade For $621 Million, Creating

2 weeks from now

Transcarent has announced its acquisition of Accolade for $7.03 per share in cash, totaling approximately $621 million, creating a combined company with over 1,400 employer and …

nasdaq.com

$7.03
OFF

Accolade To Be Acquired By Transcarent For $7.03 Per Share In Cash

2 weeks from now

Jan 8, 2025 · Transcarent, the One Place for Health and Care, and Accolade (ACCD) announced that they have entered into a definitive agreement under which Transcarent will acquire …

yahoo.com

$621
OFF

What Transcarent's $621M Acquisition Of Accolade Means For …

2 weeks from now

Jan 8, 2025 · Transcarent announced on Wednesday that it would acquire Accolade for $7.03 per share in cash, a total equity value of approximately $621 million. The artificial intelligence (AI) …

bhbusiness.com

$7.03
OFF

Transcarent To Acquire Accolade - Yahoo Finance

2 weeks from now

Jan 8, 2025 · Accolade shareholders to receive $7.03 per share in cash. SAN FRANCISCO & SEATTLE, January 08, 2025--(BUSINESS WIRE)--Transcarent, the One Place for Health and …

yahoo.com

$7.03
OFF

Transcarent To Acquire Accolade - Yahoo Finance

2 weeks from now

Jan 8, 2025 · Accolade shareholders to receive $7.03 per share in cash. SAN FRANCISCO and SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Transcarent, the One Place for Health and …

yahoo.com

$621
OFF

Accolade To Be Acquired, Taken Private By Transcarent In $621

2 weeks from now

Accolade (ACCD) agreed to be acquired and delisted by Transcarent in a $621 million deal that's expected to deliver a more personalized healthcare experience for people. ... will pay $7.03 per ...

msn.com

$621
OFF

Transcarent To Acquire Accolade In $621M Deal - Health M&A

2 weeks from now

6 days ago · Transcarent will acquire Accolade (NASDAQ: ACCD), a leader in health advocacy and primary care, for $7.03 per share in cash totalling $621M. ... The acquisition, unanimously …

hitconsultant.net

100%
OFF

Accolade Stock Soars On $621M Transcarent Acquisition Deal

2 weeks from now

Jan 8, 2025 · Investing.com -- Shares of Accolade (NASDAQ:ACCD) surged 100% following the announcement that Transcarent will acquire the health advocacy and primary care company …

investing.com

$7.03
OFF

Transcarent To Acquire Accolade - Streetinsider.com

2 weeks from now

Jan 8, 2025 · Accolade shareholders to receive $7.03 per share in cash. SAN FRANCISCO and SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Transcarent, the One Place for Health and …

streetinsider.com

$621
OFF

Transcarent Acquires Accolade For $621M, Offering 110

2 weeks from now

Jan 8, 2025 · Transcarent has announced the acquisition of Accolade (NASDAQ:ACCD) for $7.03 per share in cash, representing a total equity value of approximately $621M. The deal offers a …

stocktitan.net

$7.03
OFF

Transcarent To Acquire Accolade (ACCD) For $7.03 Per Share

2 weeks from now

Jan 8, 2025 · Transcarent, the One Place for Health and Care, and Accolade (NASDAQ: ACCD), a leader in health advocacy, expert medical opinions, and primary care, announced that they …

streetinsider.com

FAQs about Transcarent to Acquire Accolade Coupon?

How will accolade deliver 'one place for Health and care'?

Transcarent’s Generative AI WayFinding and care experiences combined with Accolade’s Advocacy, Expert Medical Opinion, and Primary Care will deliver on the promise of ‘One Place for Health and Care’ Accolade shareholders to receive $7.03 per share in cash ...

What's going on with Accolade & transcarent?

Seattle-based health care company Accolade Inc. (Nasaq: ACCD) is being acquired by telehealth startup Transcarent in a cash deal, the companies announced Wednesday. Transcarent is paying $7.03 per share, or about $621 million, which represents a roughly 110% premium over Accolade's closing stock price Tuesday. ...

Why did accolade acquire a health care company?

The companies added in their release the acquisition would create better health care experiences and lower costs for consumers, employers and payers. Accolade was founded in 2007. The company works with employers to connect workers with virtual primary care and mental health support. ...

What does accolade stand for?

Accolade ( (ACCD) ) has shared an announcement. Transcarent, a healthcare platform focused on consumer empowerment, has announced its acquisition of Accolade, a leader in health advocacy, expert medical opinions, and primary care, for $7.03 per share in cash, totaling approximately $621 million. ...

How much does accolade's merger cost?

This strategic combination has been unanimously approved by the boards of directors of both companies. The merger consideration of $7.03 per share represents a premium of approximately 110% over Accolade’s closing stock price on January 7, the last trading day prior to public disclosure of the transaction. ...

What is a transcarent & accolade merger?

This strategic merger, approved by both companies’ boards, aims to create a unified platform combining Transcarent’s AI-powered WayFinding and care experiences with Accolade’s personalized healthcare services, promising enhanced healthcare access, improved outcomes, and reduced costs. ...